Brian Ward

Brian Ward serves as the Chief Medical Officer at Aramis Biotechnologies, focusing on the development of vaccines and monoclonal antibodies utilizing plants. Additionally, Brian Ward is a Consultant Medical Officer at PharmaJet and has held the position of Professor Emeritus at McGill University since 2024, after a distinguished career in infectious diseases, microbiology, and tropical medicine. With extensive consultancy experience from academic spin-offs to major biopharmaceutical companies and an honorary lecturer role at Cayetano Heredia University, Brian Ward's contributions have significantly impacted the field. Previously, Brian Ward served as Chief Medical Officer at Medicago R & D Inc., leading initiatives on plant-made vaccines and overseeing clinical trials for influenza and SARS-COV-2 candidates. Educational background includes fellowships in microbiology and internal medicine from prestigious institutions, with an advanced degree in neuroendocrinology from the University of Oxford.